Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Inhibition of Friend murine leukemia virus activity by guanosine/thymidine oligonucleotides.

Ojwang J, Okleberry KM, Marshall HB, Vu HM, Huffman JH, Rando RF.

Antiviral Res. 1994 Sep;25(1):27-41.

PMID:
7529013
2.

Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine.

Ojwang J, Elbaggari A, Marshall HB, Jayaraman K, McGrath MS, Rando RF.

J Acquir Immune Defic Syndr. 1994 Jun;7(6):560-70.

PMID:
7513761
3.

Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine.

Fennewald SM, Mustain S, Ojwang J, Rando RF.

Antiviral Res. 1995 Jan;26(1):37-54.

PMID:
7741520
4.

T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.

Ojwang JO, Buckheit RW, Pommier Y, Mazumder A, De Vreese K, Esté JA, Reymen D, Pallansch LA, Lackman-Smith C, Wallace TL, et al.

Antimicrob Agents Chemother. 1995 Nov;39(11):2426-35.

5.

Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads.

Rando RF, Ojwang J, Elbaggari A, Reyes GR, Tinder R, McGrath MS, Hogan ME.

J Biol Chem. 1995 Jan 27;270(4):1754-60.

6.

Inhibition of murine leukemia viruses by nuclease-resistant alpha-oligonucleotides.

Lavignon M, Tounekti N, Rayner B, Imbach JL, Keith G, Paoletti J, Malvy C.

Antisense Res Dev. 1992 Winter;2(4):315-24.

PMID:
1292779
7.

Retroviral inhibition by antisense oligonucleotides determined by intracellular stability.

Ropert C, Okruszek A, Couvreur P, Malvy C.

Antisense Res Dev. 1994 Fall;4(3):207-10.

PMID:
7849491
8.
9.
10.

Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1.

Farooqui F, Sarin PS, Sun D, Letsinger RL.

Bioconjug Chem. 1991 Nov-Dec;2(6):422-6.

PMID:
1805939
11.

Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus.

Kim SG, Hatta T, Tsukahara S, Nakashima H, Yamamoto N, Shoji Y, Takai K, Takaku H.

Bioorg Med Chem. 1995 Jan;3(1):49-54.

PMID:
8612046
12.

Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry.

Luganini A, Caposio P, Landolfo S, Gribaudo G.

Antimicrob Agents Chemother. 2008 Mar;52(3):1111-20. doi: 10.1128/AAC.00987-07. Epub 2008 Jan 7.

13.

Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides.

Jairath S, Vargas PB, Hamlin HA, Field AK, Kilkuskie RE.

Antiviral Res. 1997 Feb;33(3):201-13.

PMID:
9037376
14.

Inhibitory effect of biphalin and AZT on murine Friend leukemia virus infection in vitro.

Tang JL, Lipkowski AW, Specter S.

Int J Immunopharmacol. 1998 Sep;20(9):457-66.

PMID:
9818790
15.

Properties of quadruplex oligonucleotides with anti-HIV-1 activity.

Tamura Y, Yoshida M, Suzuki J, Hiratou T, Miyano-Kurosaki N, Takai K, Takaku H.

Nucleic Acids Symp Ser. 2000;(44):181-2.

PMID:
12903328
16.
17.

Inhibition of Moloney murine leukemia virus reverse transcriptase by alpha-anomeric oligonucleotides.

Lavignon M, Bertrand JR, Rayner B, Imbach JL, Malvy C, Paoletti C.

Biochem Biophys Res Commun. 1989 Jun 30;161(3):1184-90.

PMID:
2472790
18.
20.

Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference.

Castro JE, Prada CE, Aguillon RA, Kitada S, Fukuda T, Motta M, Wu C, Dicker F, Sun G, Wang JY, Carson DA, Reed JC, Kipps TJ.

Leukemia. 2006 Apr;20(4):680-8.

PMID:
16498393

Supplemental Content

Support Center